Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
COL5A1 antisense RNA 1 (COL5A1-AS1) is a long non-coding RNA produced from the human genome on chromosome 9, transcribed from a region antisense to the protein-coding COL5A1 gene. Unlike COL5A1, which encodes the collagen type V alpha 1 chain, COL5A1-AS1 is itself non-protein-coding and belongs to the lncRNA molecular class. The precise biological role of COL5A1-AS1 is not well defined, but it may be involved in the regulation of gene expression, possibly influencing COL5A1 function by antisense mechanisms. Some database evidence links COL5A1-AS1 to classic Ehlers-Danlos Syndrome as a possible genetic marker, although evidence for a direct functional or pathogenic role remains limited. There are currently no drugs known to target COL5A1-AS1, and it is not established as a therapeutic target in clinical use[5][11][1]. Key points: - COL5A1-AS1 is an lncRNA, not a protein; many aliases and entries mistakenly imply protein-coding status. - No validated direct biological functions or disease mechanisms beyond possible gene regulation relationships. - Not considered a therapeutic, receptor, or conventional pharmacological target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on COL5A1 antisense RNA 1 (COL5A1-AS1).